Guangdong Jiaying Pharmaceutical Co Ltd (002198) — Cash Flow Reinvestment Rate
Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Cash Flow Reinvestment Rate of 0.13x as of December 2024, reinvesting CN¥5.65 Million (capex CN¥4.57 Million plus investments CN¥1.08 Million) from operating cash flow of CN¥43.63 Million. Explore Guangdong Jiaying Pharmaceutical Co Ltd (002198) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Jiaying Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2004–2025)
Historical reinvestment intensity for Guangdong Jiaying Pharmaceutical Co Ltd across 22 annual periods. Also explore Guangdong Jiaying Pharmaceutical Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Year-by-year capital reinvestment analysis for Guangdong Jiaying Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Guangdong Jiaying Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 15.57x | CN¥140.15 Million | CN¥9.00 Million | CN¥109.92 Million | ▲ +2067.8% |
| 2024 | 0.72x | CN¥43.70 Million | CN¥60.85 Million | CN¥38.70 Million | ▲ +738.6% |
| 2023 | 0.09x | CN¥8.43 Million | CN¥98.45 Million | CN¥5.06 Million | ▼ -95.7% |
| 2022 | 1.98x | CN¥53.77 Million | CN¥27.15 Million | CN¥2.74 Million | ▲ +194.4% |
| 2021 | 0.67x | CN¥34.84 Million | CN¥51.80 Million | CN¥2.34 Million | ▲ +115.9% |
| 2020 | 0.31x | CN¥30.18 Million | CN¥96.87 Million | CN¥11.68 Million | ▼ -96.2% |
| 2019 | 8.11x | CN¥105.13 Million | CN¥12.96 Million | CN¥18.82 Million | ▲ +428.7% |
| 2018 | 1.53x | CN¥95.26 Million | CN¥62.10 Million | CN¥8.95 Million | ▲ +107.1% |
| 2017 | 0.74x | CN¥22.69 Million | CN¥30.63 Million | CN¥18.44 Million | ▲ +171.7% |
| 2016 | 0.27x | CN¥14.48 Million | CN¥53.13 Million | CN¥11.98 Million | ▼ -72.8% |
| 2015 | 1.00x | CN¥42.42 Million | CN¥42.31 Million | CN¥33.42 Million | ▲ +4.9% |
| 2014 | 0.96x | CN¥98.74 Million | CN¥103.36 Million | CN¥98.74 Million | ▲ +113.3% |
| 2013 | 0.45x | CN¥8.72 Million | CN¥19.46 Million | CN¥8.72 Million | ▼ -64.1% |
| 2012 | 1.25x | CN¥6.58 Million | CN¥5.27 Million | CN¥6.58 Million | ▼ -90.9% |
| 2011 | 13.78x | CN¥10.77 Million | CN¥781.89K | CN¥10.77 Million | ▲ +661.8% |
| 2010 | 1.81x | CN¥35.62 Million | CN¥19.70 Million | CN¥35.62 Million | ▼ -34.2% |
| 2009 | 2.75x | CN¥76.95 Million | CN¥27.98 Million | CN¥76.95 Million | ▲ +1.4% |
| 2008 | 2.71x | CN¥29.05 Million | CN¥10.71 Million | CN¥29.05 Million | ▲ +473.6% |
| 2007 | 0.47x | CN¥8.68 Million | CN¥18.35 Million | CN¥8.68 Million | ▼ -3.7% |
| 2006 | 0.49x | CN¥12.95 Million | CN¥26.37 Million | CN¥12.95 Million | ▲ +42.1% |
| 2005 | 0.35x | CN¥6.09 Million | CN¥17.63 Million | CN¥6.09 Million | ▼ -83.2% |
| 2004 | 2.05x | CN¥18.04 Million | CN¥8.78 Million | CN¥18.04 Million | — |